Bellevue Life Sciences Acquisition Corp. Unit
BLACU
BLACU was delisted on the 14th of February, 2025.
10 hedge funds and large institutions have $7.63M invested in Bellevue Life Sciences Acquisition Corp. Unit in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 4 closing their positions.
23% less funds holding
Funds holding: 13 → 10 (-3)
58% less capital invested
Capital invested by funds: $18.1M → $7.63M (-$10.5M)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$63.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$6.33M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.66M |
| 3 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$1.48M |
| 4 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$1.07M |
| 5 |
SIA
Schechter Investment Advisors
Birmingham,
Michigan
|
-$21.2K |
BLACU Hedge Fund Activity: Q3 2023 in Review
10 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Bellevue Life Sciences Acquisition Corp. Unit (BLACU) for Q3 2023, worth a combined $7.63M — down 58% from $18.1M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BLACU and 1 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was Clear Street, opening a new position worth an estimated $63.5K. The largest seller was Periscope Capital, exiting entirely with an estimated $6.33M sold.
- 10 institutional investors held Bellevue Life Sciences Acquisition Corp. Unit (BLACU) as of Q3 2023, down from 13 in Q2 2023.
- Funds reported $7.63M of Bellevue Life Sciences Acquisition Corp. Unit stock for Q3 2023, down 58% quarter-over-quarter.
- 1 fund opened new Bellevue Life Sciences Acquisition Corp. Unit positions in Q3 2023 and 4 closed out, a net change of -3 holders.
- The largest Bellevue Life Sciences Acquisition Corp. Unit buyer in Q3 2023 was Clear Street, an estimated $63.5K added.
- The largest Bellevue Life Sciences Acquisition Corp. Unit seller in Q3 2023 was Periscope Capital, an estimated $6.33M sold.
Based on aggregated 13F filings for Q3 2023.